3rd generation TLR4 agonist small-molecule designed for effective & safe cancer therapy

Redefining Front-Line Immunotherapy

University Paris Saclay

University Paris Saclay

HEPHAISTOS-Pharma was present at the Event organized by the University Paris Saclay for its collaborating companies. We are glad to collaborate locally with the University’s research teams, students and teachers and we will continue to collaborate in the...
European Grant

European Grant

HEPHAISTOS-Pharma obtained a European Grant for its development program of immuno-stimulators. The Inno-Boost-LPS project aims to develop innovative immuno-stimulators, based on natural Lipopolysaccharides (LPS) derivatives, to boost the efficacy of vaccines and...